Log in

NASDAQ:CYTKCytokinetics SEC Filings & 10K Form

$11.96
-0.09 (-0.75 %)
(As of 04/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$11.45
Now: $11.96
$12.24
50-Day Range
$8.75
MA: $12.86
$16.30
52-Week Range
$7.72
Now: $11.96
$16.96
Volume653,092 shs
Average Volume931,141 shs
Market Capitalization$711.14 million
P/E RatioN/A
Dividend YieldN/A
Beta1.18

SEC Filings

Cytokinetics (NASDAQ:CYTK) SEC Filings

DateFilerForm TypeView
04/01/2020
3:53 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cytokinetics (Subject)
Form SC 13G/A
03/30/2020
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2020
8:44 PM
Cytokinetics (Filer)
Form DEFA14A
03/20/2020
2:21 PM
Cytokinetics (Issuer)
GAGE L PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
2:21 PM
Cytokinetics (Issuer)
GAGE L PATRICK (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
03/09/2020
3:33 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:33 PM
Cytokinetics (Issuer)
SCHLOSSBERG MARK A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:33 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:33 PM
Cragg David (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:32 PM
Cytokinetics (Issuer)
Jaw Ching (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:32 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
3:36 PM
Cytokinetics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/04/2020
9:52 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
5:19 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
5:19 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
5:18 PM
Cragg David (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
5:18 PM
Cytokinetics (Issuer)
Jaw Ching (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
2:39 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
2:39 PM
Cytokinetics (Issuer)
Jaw Ching (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
2:38 PM
Cragg David (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
1:49 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2020
1:35 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2020
5:00 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Cytokinetics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
4:40 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
4:40 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
4:39 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
4:39 PM
Califf Robert (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:59 PM
Cytokinetics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
02/14/2020
3:20 PM
Cytokinetics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
02/14/2020
2:00 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Cytokinetics (Subject)
Form SC 13G/A
02/12/2020
10:01 AM
Cytokinetics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/12/2020
7:13 AM
Cytokinetics (Subject)
DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
02/07/2020
3:44 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2020
11:58 AM
Califf Robert (Reporting)
Cytokinetics (Issuer)
Form 4/A
01/29/2020
11:57 AM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4/A
01/29/2020
11:57 AM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4/A
01/29/2020
11:54 AM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4/A
01/23/2020
4:01 PM
Cytokinetics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G/A
01/16/2020
3:53 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
6:51 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
6:47 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
5:55 PM
Califf Robert (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:55 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:55 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
5:52 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2020
1:22 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
3:37 PM
Cytokinetics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G
12/12/2019
6:49 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Cytokinetics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
6:45 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Cytokinetics (Issuer)
LAMPERT MARK N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/06/2019
3:42 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
4:02 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
3:31 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
4:08 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
5:15 AM
Cytokinetics (Subject)
Form FWP
11/08/2019
5:11 AM
Cytokinetics (Filer)
Form 305B2
11/06/2019
4:02 PM
Cytokinetics (Filer)
Form 424B5
11/06/2019
3:02 PM
Cytokinetics (Filer)
Form S-3ASR
11/01/2019
3:16 PM
Cytokinetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
3:02 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
4:42 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2019
4:13 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
4:08 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2019
3:48 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2019
4:45 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
4:07 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
4:04 PM
Cytokinetics (Filer)
Form 424B5
08/09/2019
3:06 PM
Cytokinetics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
3:26 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
3:23 PM
Cytokinetics (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
Form SC 13G
07/25/2019
6:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
4:25 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:19 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
6:41 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:52 PM
Blum Robert I (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
4:37 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
4:08 PM
Cytokinetics (Issuer)
Wong Robert (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/21/2019
4:22 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2019
11:15 PM
Cytokinetics (Filer)
Form EFFECT
05/17/2019
4:16 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
4:10 PM
Cytokinetics (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:08 PM
Cytokinetics (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:08 PM
Cytokinetics (Issuer)
Kaye Edward M. MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:08 PM
Cytokinetics (Issuer)
SMITH SANDFORD D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:07 PM
Cytokinetics (Issuer)
HENDERSON JOHN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:07 PM
Cytokinetics (Issuer)
GAGE L PATRICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:07 PM
COSTA SANTO J (Reporting)
Cytokinetics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
8:32 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
4:25 PM
Cytokinetics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
05/09/2019
3:01 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
1:44 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
4:34 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
4:14 PM
Cytokinetics (Filer)
Form CT ORDER
04/05/2019
6:11 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
7:30 AM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
7:58 PM
Cytokinetics (Filer)
Form 424B3
03/07/2019
5:05 AM
Cytokinetics (Filer)
Form 424B5
03/04/2019
3:15 PM
Cytokinetics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
3:05 PM
Cytokinetics (Issuer)
Malik Fady Ibraham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
3:05 PM
Cytokinetics (Issuer)
Jaw Ching (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel